Safety of a potential new treatment to manage complications from sickle cell disease

A drug approved to treat pulmonary arterial hypertension may be effective at managing hypertension and end-organ damage in patients with sickle cell disease, according to a new study published in

Anticoagulation may have greater benefit in patients with vascular disease

Graphical Abstract. Credit: European Heart Journal (2024). DOI: 10.1093/eurheartj/ehae596 A combined subgroup analysis of the similar trials NOAH—AFNET 6 and ARTESiA has revealed that patients with device-detected atrial fibrillation and

Blood clotting may be the root cause of Long COVID syndrome, research shows

New evidence shows that patients with Long COVID syndrome continue to have higher measures of blood clotting, which may help explain their persistent symptoms, such as reduced physical fitness and